| || |
Dr. Fred Mermelstein (Left) and Dr. Carl Novina (Right) will serve as Harvard Biotech Incubator's (HBI) Academic and Industry Advisors for the 2018-2019 academic year. HBI is a part of the Harvard Biotech Club, which focuses on teaching students and fellows the key concepts of biotechnology and drug development, through inception to commercialization. This will be Dr. Mermelstein and Dr. Novina's second year as advisors for the HBI. This year, they will be working on developing a novel drug discovery platform aimed at disrupting lncRNA-protein interactions. Read more about the incubator here.